Holocene Advisors
COGT icon

Holocene Advisors’s Cogent Biosciences COGT Stock Holding History

Holocene Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Sell
32,832
-2,217,364
-99% -$77.6M ﹤0.01% 645
2026
Q1 		$86.6M Buy
2,250,196
+1,071,988
+91% +$39.6M 0.21% 125
2025
Q4 		$41.8M Buy
1,178,208
+1,060,292
+899% +$29.8M 0.09% 225
2025
Q3 		$1.69M Buy
+117,916
New +$1.4M ﹤0.01% 557

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Holocene Advisors's COGT Position: Q2 2026 in Review

Holocene Advisors reduced its Cogent Biosciences (COGT) stake by 99% in Q2 2026, selling an estimated $77.6M and leaving 32,832 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #645.

Holocene Advisors first reported a position in COGT in Q3 2025 and has held it in 4 quarters since. The position peaked at $86.6M in Q1 2026. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Holocene Advisors held 32,832 shares of Cogent Biosciences worth $1.27M as of Q2 2026.
  • Holocene Advisors sold 2,217,364 Cogent Biosciences shares in Q2 2026, an estimated $77.6M.
  • Cogent Biosciences made up ﹤0.01% of Holocene Advisors's portfolio in Q2 2026, its #645 holding.
  • Holocene Advisors first reported a position in Cogent Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Holocene Advisors's Cogent Biosciences position peaked at $86.6M in Q1 2026.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Holocene Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.